NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









2cureX

2cureX

Private
CopenhagenHealthcare & Life Scienceshttps://www.2curex.se/

Last Round

Private Placement

Apr 22, 2026

Est. Valuation

$3.8M

Total Funding Raised

$10.34M

Company Overview

2cureX is a medical technology company that develops functional drug sensitivity testing solutions, including its proprietary IndiTreat platform, to provide personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision medicinecancer diagnosticsdrug sensitivity testingtumoroidsfunctional oncologypersonalized cancer therapy3D tumor modelsin-vitro assayscancer drug screeningorganoid technologyclinical decision supportdiagnostic platformmedical diagnosticsbiotechlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

2cureX Comparables

Compare 2cureX with similar companies based on industry and business-model similarity.

2cureX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PreComb Therapeutics
86%
SpheroTec GmbH
84%
VitroScan
83%

2cureX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementApr 22, 2026
DebtJun 17, 2024
Private PlacementJun 17, 2024
GrantFeb 1, 2021
Private PlacementJul 6, 2020
Grant
Apr 1, 2020

2cureX Investors

Notable investors and investment history

2cureX investors
InvestorRounds
KoodosPrivate Placement
Kinled HoldingDebt, Private Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2024

    $260K round led by Kinled Holding

  • Feb 1, 2021

    Received grant funding from the European Commission.

2cureX Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

2cureX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 2cureX's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Year Founded2006
Last FundingApr 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.